The Search for Antiparasitic Agents

Tag E. Mansour

doi:10.1017/CBO9780511546440.002

1 - The Search for Antiparasitic Agents

Published online by Cambridge University Press: 11 August 2009

Tag E. Mansour

With

Joan MacKinnon Mansour

Show author details

Tag E. Mansour: Affiliation:
Stanford University, California

Book contents

Get access

Summary

Early Beginnings of Chemotherapy

Historical records from almost every culture have examples of successful treatment of different ailments by potions, mainly from vegetable sources and occasionally from animals. A good example of an antiparasitic agent is cinchona bark (quinine), which was used against malaria by the early Peruvians and introduced to the Western World by the Jesuits. Extracts of male fern and of santonin obtained from Artemisia maritima var. anthelmintica were held in high regard as anthelmintics by Theophratus (370–285 b.c.) and Galen (a.d. 130–201) and were also recommended as effective anthelmintics until the 1940s and 1950s (Goodman & Gilman, 1955).

The beginning of chemotherapy as a science had to await the establishment of the germ theory of infection by Louis Pasteur more than a century ago. Rather than accepting the concept of spontaneous generation of infection, Pasteur suggested that diseases are caused by microbes that are transmitted among humans. Pasteur's inspiration for this theory came during his early studies on fermentation for the wine industry in France. Pasteur's contributions influenced bacteriology, immunology, the study of antibiotics, sterilization, epidemiology, and public health. This remarkable era was followed by the discovery and identification of many of the infectious microorganisms and methods for their culture in the laboratory and for infecting experimental animals. The study of parasites was initiated at the time of Sir Patrick Manson (1844–1922), who established the first institute for studying and teaching about tropical diseases: The London School of Hygiene and Tropical Medicine.

Type: Chapter
Information: Chemotherapeutic Targets in Parasites
Contemporary Strategies
, pp. 1 - 18

DOI: https://doi.org/10.1017/CBO9780511546440.002 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2002

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Basch, P. F. & Rhine, W. D. (1983). Schistosoma mansoni: Reproductive potential of male and female worms cultured in vitro. J Parasitol, 69(3), 567–569CrossRef Google Scholar PubMed

Baumler, E. (1965). In Search of the Magic Bullet. London: Thames and Hudson

Broom, A. D. (1989). Rational design of enzyme inhibitors: Multisubstrate analogue inhibitors. J Med Chem, 32(1), 2–7CrossRef Google Scholar PubMed

Bueding, E. (1950). Carbohydrate metabolism of Schistosoma mansoni. J Gen Physiol, 33, 475–495CrossRef Google Scholar PubMed

Bueding, E., Saz, H. & Farrow, G. (1959). The effect of piperazine on succinat production by Ascaris lumbricoides. Brit J Pharmacol, 14, 497–500Google Scholar

Burbaum, J. J., Ohlmeyer, M. H., Reader, J. C., Henderson, I., Dillard, L. W., Li, G., Randle, T. L., Sigal, N. H., Chelsky, D. & Baldwin, J. J. (1995). A paradigm for drug discovery employing encoded combinatorial libraries. Proc Natl Acad Sci USA, 92(13), 6027–6031CrossRef Google Scholar PubMed

Carroll, C. D. & Orlowski, M. (1998). Screening aspartyl proteases with combinatorial libraries. Adv Exp Med Biol, 436, 375–380CrossRef Google Scholar PubMed

Ehrlich, P. (1913). Chemotherapeutics: Scientific princples, methods, and results. Lancet, 2, August 16, 445–451Google Scholar

Fairlamb, A. H. & Cerami, A. (1992). Metabolism and functions of trypanothione in the Kinetoplastida. Annu Rev Microbiol, 46, 695–729CrossRef Google Scholar PubMed

Falcone, F. H., Zahner, H., Schlaak, M. & Haas, H. (1995). In vitro cultivation of third-stage larvae of Brugia malayi to the young adult stage. Trop Med Parasitol, 46(4), 230–234Google Scholar PubMed

Gallop, M. A., Barrett, R. W., Dower, W. J., Fodor, S. P. & Gordon, E. M. (1994). Applications of combinatorial technologies to drug discovery. 1. Background and peptide combinatorial libraries. J Med Chem, 37(9), 1233–1251CrossRef Google Scholar PubMed

Goodman, L. & Gilman, A. (1955). The Pharmacological Basis of Therapeutics (2nd ed.). New York: MacMillan

Gordon, E. M., Barrett, R. W., Dower, W. J., Fodor, S. P. & Gallop, M. A. (1994). Applications of combinatorial technologies to drug discovery. 2. Combinatorial organic synthesis, library screening strategies, and future directions. J Med Chem, 37(10), 1385–1401CrossRef Google Scholar PubMed

Homann, M. & Goringer, H. U. (1999). Combinatorial selection of high affinity RNA ligands to live African trypanosomes. Nucleic Acids Res, 27(9), 2006–2014CrossRef Google Scholar PubMed

Hudson, A. (1994). The contribution of empiricism to antiparasite drug discovery. Parasitol Today, 10, 387–389CrossRef Google Scholar PubMed

James, K. (1988). Quantitative structure–activity relationships and drug design. In H. Smith (Ed.), Smith and Williams Introduction to the Principles of Drug Design (2nd ed., pp. 240–264). London: Butterworth & Co

Johnson, R. K., Inouye, T., Goldin, A. & Stark, G. R. (1976). Antitumor activity of N-(phosphonacetyl)-L-aspartic acid, a transition-state inhibitor of aspartate transcarbamylase. Cancer Res, 36(8), 2720–2725Google Scholar PubMed

Mansour, T. E. (1979). Chemotherapy of parasitic worms: New biochemical strategies. Science, 205(4405), 462–469CrossRef Google Scholar PubMed

Nakajima-Shimada, J., Hirota, Y. & Aoki, T. (1996). Inhibition of Trypanosoma cruzi growth in mammalian cells by purine and pyrimidine analogs. Antimicrob Agents Chemother, 40(11), 2455–2458Google Scholar PubMed

Pan, A. A. (1984). Leishmania mexicana: Serial cultivation of intracellular stages in a cell-free medium. Exp Parasitol, 58(1), 72–80CrossRef Google Scholar

Pfefferkorn, E. R. & Pfefferkorn, L. C. (1977). Specific labeling of intracellular Toxoplasma gondii with uracil. J Protozool, 24(3), 449–453CrossRef Google Scholar PubMed

Remington, J. S., Krahenbuhl, J. L. & Mendenhall, J. W. (1972). A role for activated macrophages in resistance to infection with Toxoplasma. Infect Immun, 6(5), 829–834Google Scholar PubMed

Schmidt, L. H., Crosby, R., Rasco, J. & Vaughan, D. (1978). Antimalarial activities of various 4-quinolonemethanols with special attention to WR-142,490 (mefloquine). Antimicrob Agents Chemother, 13(6), 1011–1030CrossRef Google Scholar

Smith, H. (1988). Introduction to the Principles of Drug Design (2nd ed.). London: Wright

Smyth, J. (1990). In vitro Cultivation of Parasitic Helminths. Boca Raton, FL: CRC Press

Stark, G. R. & Bartlett, P. A. (1983). Design and use of potent, specific enzyme inhibitors. Pharmacol Ther, 23(1), 45–78CrossRef Google Scholar PubMed

Thompson, D. P., Klein, R. D. & Geary, T. G. (1996). Prospects for rational approaches to anthelmintic discovery. Parasitology, 113(Suppl), S217–238CrossRef Google Scholar PubMed

Trager, W. & Jensen, J. B. (1976). Human malaria parasites in continuous culture. Science, 193(4254), 673–675CrossRef Google Scholar PubMed

Upcroft, J. A., Campbell, R. W., Benakli, K., Upcroft, P. & Vanelle, P. (1999). Efficacy of new 5-nitroimidazoles against metronidazole-susceptible and -resistant Giardia, Trichomonas, and Entamoeba spp. Antimicrob Agents Chemother, 43(1), 73–76Google Scholar PubMed

Wang, C. C. (1997). Validating targets for antiparasite chemotherapy. Parasitology, 114(Suppl), S31–44Google Scholar PubMed

Yoshida, T., Stark, G. R. & Hoogenraad, J. (1974). Inhibition by N-(phosphonacetyl)-L-aspartate of aspartate transcarbamylase activity and drug-induced cell proliferation in mice. J Biol Chem, 249(21), 6951–6955Google Scholar

Book contents

1 - The Search for Antiparasitic Agents

Summary

Access options

References

Save book to Kindle

Save book to Dropbox

Save book to Google Drive